List of Tables
Table 1. Continuous Subcutaneous Insulin Infusion Therapy Market Trends
Table 2. Continuous Subcutaneous Insulin Infusion Therapy Market Drivers & Opportunity
Table 3. Continuous Subcutaneous Insulin Infusion Therapy Market Challenges
Table 4. Continuous Subcutaneous Insulin Infusion Therapy Market Restraints
Table 5. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Continuous Subcutaneous Insulin Infusion Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Continuous Subcutaneous Insulin Infusion Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Continuous Subcutaneous Insulin Infusion Therapy
Table 10. Global Continuous Subcutaneous Insulin Infusion Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Medtronic Basic Information List
Table 32. Medtronic Description and Business Overview
Table 33. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Continuous Subcutaneous Insulin Infusion Therapy Business of Medtronic (2019-2024)
Table 35. Medtronic Recent Developments
Table 36. Roche Basic Information List
Table 37. Roche Description and Business Overview
Table 38. Roche Continuous Subcutaneous Insulin Infusion Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Continuous Subcutaneous Insulin Infusion Therapy Business of Roche (2019-2024)
Table 40. Roche Recent Developments
Table 41. SOOIL Basic Information List
Table 42. SOOIL Description and Business Overview
Table 43. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Continuous Subcutaneous Insulin Infusion Therapy Business of SOOIL (2019-2024)
Table 45. SOOIL Recent Developments
Table 46. Tandem Diabetes care Basic Information List
Table 47. Tandem Diabetes care Description and Business Overview
Table 48. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Continuous Subcutaneous Insulin Infusion Therapy Business of Tandem Diabetes care (2019-2024)
Table 50. Tandem Diabetes care Recent Developments
Table 51. Insulet Corp Basic Information List
Table 52. Insulet Corp Description and Business Overview
Table 53. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Continuous Subcutaneous Insulin Infusion Therapy Business of Insulet Corp (2019-2024)
Table 55. Insulet Corp Recent Developments
Table 56. Valeritas Basic Information List
Table 57. Valeritas Description and Business Overview
Table 58. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Continuous Subcutaneous Insulin Infusion Therapy Business of Valeritas (2019-2024)
Table 60. Valeritas Recent Developments
Table 61. Microport Basic Information List
Table 62. Microport Description and Business Overview
Table 63. Microport Continuous Subcutaneous Insulin Infusion Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Continuous Subcutaneous Insulin Infusion Therapy Business of Microport (2019-2024)
Table 65. Microport Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Continuous Subcutaneous Insulin Infusion Therapy Downstream Customers
Table 69. Continuous Subcutaneous Insulin Infusion Therapy Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Continuous Subcutaneous Insulin Infusion Therapy Product Picture
Figure 2. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Continuous Subcutaneous Insulin Infusion Therapy Report Years Considered
Figure 5. Global Continuous Subcutaneous Insulin Infusion Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Continuous Subcutaneous Insulin Infusion Therapy Revenue in 2023
Figure 7. Continuous Subcutaneous Insulin Infusion Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Normal Picture
Figure 9. Patch Pump Picture
Figure 10. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Retail Pharmacy
Figure 14. Product Picture of Other
Figure 15. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Continuous Subcutaneous Insulin Infusion Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Continuous Subcutaneous Insulin Infusion Therapy Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Continuous Subcutaneous Insulin Infusion Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Therapy Sales Value (%), (2019-2030)
Figure 28. United States Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (%), 2023 VS 2030
Figure 34. China Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (%), 2023 VS 2030
Figure 36. China Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (%), 2023 VS 2030
Figure 46. India Continuous Subcutaneous Insulin Infusion Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Type (%), 2023 VS 2030
Figure 48. India Continuous Subcutaneous Insulin Infusion Therapy Sales Value by Application (%), 2023 VS 2030
Figure 49. Continuous Subcutaneous Insulin Infusion Therapy Industrial Chain
Figure 50. Continuous Subcutaneous Insulin Infusion Therapy Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
